ABL1 and precursor B-cell acute lymphoblastic leukemia: We subsequently found that although imatinib had a weak effect on the survival of mice with B-ALL induced by BCR-ABL, coinhibi-tion of BCR-ABL kinase activity and SFKs maintained long-term survival [23].